Literature DB >> 15378741

Proteome analysis of Neisseria meningitidis serogroup A.

Giulia Bernardini1, Giovanni Renzone, Maurizio Comanducci, Roberta Mini, Simona Arena, Chiara D'Ambrosio, Stefania Bambini, Lorenza Trabalzini, Guido Grandi, Paola Martelli, Mark Achtman, Andrea Scaloni, Giulio Ratti, Annalisa Santucci.   

Abstract

Neisseria meningitidis is an encapsulated Gram-negative bacterium responsible for significant morbidity and mortality worldwide. Meningococci are opportunistic pathogens, carried in the nasopharynx of approximately 10% of asymptomatic adults. Occasionally they enter the bloodstream to cause septicaemia and meningitis. Meningococci are classified into serogroups on the basis of polysaccharide capsule diversity, and serogroup A strains have caused major epidemics mainly in the developing world. Here we describe a two-dimensional gel electrophoresis protein map of the serogroup A strain Z4970, a clinical isolate classified as ancestral to several pandemic waves. To our knowledge this is the first systematically annotated proteomic map for N. meningitidis. Total protein samples from bacteria grown on GC-agar were electrophoretically separated and protein species were identified by matrix-assisted laser desorption/ionization time of flight spectrometry. We identified the products of 273 genes, covering several functional classes, including 94 proteins so far considered as hypothetical. We also describe several protein species encoded by genes reported by DNA microarray studies as being regulated in physiological conditions which are relevant to natural meningococcal pathogenicity. Since menA differs from other serogroups by having a fairly stable clonal population structure (i.e. with a low degree of variability), we envisaged comparative mapping as a useful tool for microevolution studies, in conjunction with established genotyping methods. As a proof of principle, we performed a comparative analysis on the B subunit of the meningococcal transferrin receptor, a vaccine candidate encoded by the tbpB gene, and a known marker of population diversity in meningococci. The results show that TbpB spot pattern variation observed in the maps of nine clinical isolates from diverse epidemic spreads, fits previous analyses based on allelic variations of the tbpB gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378741     DOI: 10.1002/pmic.200400946

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  11 in total

1.  Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant.

Authors:  Jeannette N Williams; Paul J Skipp; Holly E Humphries; Myron Christodoulides; C David O'Connor; John E Heckels
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

2.  Quantitative proteome analysis using D-labeled N-ethylmaleimide and 13C-labeled iodoacetanilide by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Sadamu Kurono; Tamie Kurono; Naoka Komori; Satomi Niwayama; Hiroyuki Matsumoto
Journal:  Bioorg Med Chem       Date:  2006-10-16       Impact factor: 3.641

3.  Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates.

Authors:  Jeannette N Williams; Paul J Skipp; C David O'Connor; Myron Christodoulides; John E Heckels
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

4.  Comparison of the RpoH-dependent regulon and general stress response in Neisseria gonorrhoeae.

Authors:  Ishara C Gunesekere; Charlene M Kahler; David R Powell; Lori A S Snyder; Nigel J Saunders; Julian I Rood; John K Davies
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

5.  Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7.

Authors:  Gunnstein Norheim; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; Yared Merid; E Arne Høiby; Dominique A Caugant; Elisabeth Fritzsønn; Torill Tangen; Tsegaye Alebel; Degu Berhanu; Morten Harboe; Einar Rosenqvist
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

6.  Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.

Authors:  Gunnstein Norheim; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; Yared Merid; E Arne Høiby; Dominique A Caugant; Elisabeth Fritzsønn; Torill Tangen; Berhanu Melak; Degu Berhanu; Morten Harboe; Jan Kolberg; Einar Rosenqvist
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

7.  Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.

Authors:  Gunnstein Norheim; Einar Rosenqvist; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; E Arne Høiby; Tsegaye Alebel; Degu Berhanu; Yarid Merid; Morten Harboe; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Proteomic analysis of sera from common variable immunodeficiency patients undergoing replacement intravenous immunoglobulin therapy.

Authors:  Giuseppe Spadaro; Concetta D'Orio; Arturo Genovese; Antonella Galeotafiore; Chiara D'Ambrosio; Stefano Di Giovanni; Monica Vitale; Mario Capasso; Vincenzo Lamberti; Andrea Scaloni; Gianni Marone; Nicola Zambrano
Journal:  J Biomed Biotechnol       Date:  2011-09-22

9.  Comparative shotgun proteomic analysis of Clostridium acetobutylicum from butanol fermentation using glucose and xylose.

Authors:  Kumaran Sivagnanam; Vijaya Gs Raghavan; Manesh Shah; Robert L Hettich; Nathan C Verberkmoes; Mark G Lefsrud
Journal:  Proteome Sci       Date:  2011-10-18       Impact factor: 2.480

10.  Towards the immunoproteome of Neisseria meningitidis.

Authors:  Tom A Mendum; Jane Newcombe; Celia L McNeilly; Johnjoe McFadden
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.